Zobrazeno 1 - 10
of 22
pro vyhledávání: '"H Tanasichuk"'
Autor:
D.S. Fulton, R.C. Urtasun, K.H. Shin, P.H.S. Geggie, H. Thomas, P.J. Muller, J. Moody, H. Tanasichuk, B. Mielke, E. Johnson, B. Curry
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 10:1709-1712
Multiple daily fractionated radiation therapy (MDF) may be more effective than conventionally fractionated radiation therapy (CF) in the treatment of malignant glioma. The hypoxic cell sensitizer misonidazole (MISO) could be more effective when emplo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e37c0252b332331e346a4c0b8e9c6e7
https://doi.org/10.1016/0360-3016(84)90533-9
https://doi.org/10.1016/0360-3016(84)90533-9
Autor:
J D Miller, B Mielke, M L Feldstein, J Partington, O Agboola, D B Russell, H Tanasichuk, Raul C. Urtasun
Publikováno v:
British Journal of Cancer
As a continuation of a previous controlled trial using "high-dose" metronidazole as a specific sensitizer of hypoxic cells, we used a more efficient nitroimidazole derivative (misonidazole, MISO) in combination with higher doses of radiation in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfac639d9babb7b7064b574529b1af90
https://doi.org/10.1038/bjc.1982.171
https://doi.org/10.1038/bjc.1982.171
Autor:
Edward S. Johnson, Paul J. Muller, Burnadette Curry, Raul C. Urtasun, Peter H.S. Geggie, Michael Feldstein, Harvy Thomas, Dorcus Fulton, Bruce Mielke, Kyu H. Shin, H. Tanasichuk
Publikováno v:
Cancer. 56:758-760
Various attempts have been made to improve the effectiveness of radiation in the treatment of cerebral malignant astrocytomas. A trend favoring multiple daily fractionated (MDF) radiation therapy over conventional single daily fractionated (CF) radia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7be2694f6298d8ff8e8aedbd3208056
https://doi.org/10.1002/1097-0142(19850815)56:4<758::aid-cncr2820560410>3.0.co
https://doi.org/10.1002/1097-0142(19850815)56:4<758::aid-cncr2820560410>3.0.co
Publikováno v:
Journal of neuro-oncology. 4(4)
CCNU chemotherapy prolongs survival of patients with primary brain tumor when given at the time of tumor progression following radiation therapy. Used as single agent, response rates of 30 to 80 per cent have been reported with median response durati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d791db9770f07173d4a3c1022c4a0d99
https://pubmed.ncbi.nlm.nih.gov/3033164
https://pubmed.ncbi.nlm.nih.gov/3033164
Autor:
D. Koziol, Raul C. Urtasun, R. Turner, O. Agboola, H R Rabin, H. Tanasichuk, J. Raleigh, Dorcas Fulton
Publikováno v:
International journal of radiation oncology, biology, physics. 8(3-4)
Although considerable laboratory in vitro and in vivo evidence is now available suggesting that misonidazole (MISO) enhances chemotherapy tumor responses, experience with human tumors is limited. Further, the mechanism of this enhancement is not defi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81c0803a1537b0e05ce41018245b96cf
https://pubmed.ncbi.nlm.nih.gov/7107356
https://pubmed.ncbi.nlm.nih.gov/7107356
Autor:
K H, Shin, R C, Urtasun, D, Fulton, P H, Geggie, H, Tanasichuk, H, Thomas, P J, Muller, B, Curry, B, Mielke, E, Johnson
Publikováno v:
Cancer. 56(4)
Various attempts have been made to improve the effectiveness of radiation in the treatment of cerebral malignant astrocytomas. A trend favoring multiple daily fractionated (MDF) radiation therapy over conventional single daily fractionated (CF) radia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d88dc977d3fbc7faf8e0a859dd1108a3
https://pubmed.ncbi.nlm.nih.gov/3893680
https://pubmed.ncbi.nlm.nih.gov/3893680
Publikováno v:
International journal of radiation oncology, biology, physics. 10(9)
Neurotoxicity induced by misonidazole (MISO) and desmethylmisonidazole (DMM) has become the dose limiting factor in clinical work. In 1981, we reported a preliminary study suggestive that Dexamethasone (DEXA) does have a protective effect against per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e94aa6d40ba137b72369accc240ff7f3
https://pubmed.ncbi.nlm.nih.gov/6480455
https://pubmed.ncbi.nlm.nih.gov/6480455
Autor:
D. Koziol, J. Raleigh, A.R. Turner, Raul C. Urtasun, O. Agboola, H. Tanasichuk, Dorcas Fulton
Publikováno v:
International journal of radiation oncology, biology, physics. 8(3-4)
With a view to modifying misonidazole (MISO) neurotoxicity, we initiated a randomized clinical study to assess a possible drug interaction and toxicity protection when dexamethasone (DXM) is administered concomittantly with MISO. The ongoing study co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0a4e62c6e17300a39c013e48d90ad8c
https://pubmed.ncbi.nlm.nih.gov/7107353
https://pubmed.ncbi.nlm.nih.gov/7107353
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.